Ozuriftamab Vedotin | m-entrepreneurship.com

Product Name :
Ozuriftamab Vedotin

Search keywords :
Ozuriftamab

drugId :
null

Target Vo:
Tyrosine-protein kinase transmembrane receptor ROR2

Target Vo Short Name :
ROR2

Moa_Name:
Tyrosine-protein kinase transmembrane receptor ROR2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bioatla

Active Company_Name :
BioAtla Inc

Active Indication_Name:
Squamous Cell Carcinoma of Head and Neck

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD31 Antibody (YA806)
CD11c Antibody
Caspase-6 Antibody: Caspase-6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Caspase-6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts